PMS (postmarket surveillance) key focus in CDRH (Center for Devices and Radiological Health) guidance document plans
This article was originally published in Clinica
Executive Summary
Based on its list of guidance documents under development, the FDA's device centre (CDRH) has charted an ambitious workplan over the next 12 months. Most of the items included in the agency's annual guidance document agenda published yesterday are highly product specific.